chr10-133279828-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006659.4(TUBGCP2):c.2647C>A(p.Gln883Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000358 in 1,593,702 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006659.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TUBGCP2 | NM_006659.4 | c.2647C>A | p.Gln883Lys | missense_variant | 18/18 | ENST00000252936.8 | NP_006650.1 | |
TUBGCP2 | NM_001256617.2 | c.2731C>A | p.Gln911Lys | missense_variant | 19/19 | NP_001243546.1 | ||
TUBGCP2 | NM_001256618.2 | c.2257C>A | p.Gln753Lys | missense_variant | 17/17 | NP_001243547.1 | ||
TUBGCP2 | NR_046330.2 | n.3367C>A | non_coding_transcript_exon_variant | 18/18 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152248Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000186 AC: 4AN: 214818Hom.: 0 AF XY: 0.0000171 AC XY: 2AN XY: 117248
GnomAD4 exome AF: 0.0000368 AC: 53AN: 1441336Hom.: 0 Cov.: 31 AF XY: 0.0000363 AC XY: 26AN XY: 715714
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152366Hom.: 0 Cov.: 33 AF XY: 0.0000268 AC XY: 2AN XY: 74512
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 22, 2022 | The c.2647C>A (p.Q883K) alteration is located in exon 18 (coding exon 17) of the TUBGCP2 gene. This alteration results from a C to A substitution at nucleotide position 2647, causing the glutamine (Q) at amino acid position 883 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at